Sean McClain, the Chief Executive Officer of Absci Corp, has reported a transaction involving 23,293 shares of common stock. The transaction was filed on October 14, 2026, and is significant as it highlights the ongoing changes in executive stock holdings within the company.
Absci Corp, identified by the Central Index Key 0001672688, operates in the commercial physical and biological research sector. The company is based in Vancouver, Washington, and has undergone several name changes in its history, with its most recent name change occurring on October 26, 2020, when it transitioned from AbSci, Inc. to Absci Corp.
According to the filing, McClain's transaction took place on October 12, 2026, with a price of $10.16 per share. This transaction involved shares withheld by the issuer to cover tax obligations related to the vesting of restricted stock units, rather than a discretionary trade. Following this transaction, McClain continues to hold 8,632,262 shares of common stock in Absci Corp.
This update may have implications for the company's stakeholders, including investors and employees, as it reflects the ongoing management of executive compensation and stock ownership. The commercial physical and biological research sector may also experience shifts in management dynamics as companies navigate their operational landscapes.
The filing does not specify what actions may follow this transaction.